Home / News / Page 5

News

Stay informed with Dissolution Tester News, featuring the latest advancements, industry trends, and updates in pharmaceutical testing technology. Discover new features, regulatory changes, and innovative solutions for accurate drug release analysis, ensuring quality and compliance in drug development and manufacturing.

Filter by Popular Tags


Tablet Dissolution Testing Equipment India

Tablet Dissolution Testing Equipment India: Designed for 2026's Flexible Formulation Pipeline

Tablet Dissolution Testing Equipment India has come a long way from the foundational stages of quality control. As pharmaceutical pipelines diversify into complex oral solids, patches, parenterals, and semi-solids, labs ...

By hqt

2026-05-18

Transdermal Diffusion Testing Equipment

Transdermal Diffusion Testing Equipment: Why 2026 Demands Smarter Automation

Transdermal Diffusion Testing Equipment has been crucial for IVRT and IVPT studies. However, manual workflows posed a compliance risk for 2026 and beyond. The global automated diffusion cell market, driven ...

By hqt

2026-04-23

Franz Diffusion Cell Apparatus for Patches

Double Your Data: The Dual-Group Franz Diffusion Cell Apparatus for Patches

The transdermal patches market is booming—$8.02 billion in 2026, rising to $13.27 billion by 2034. As labs rush to develop new patches, the Franz diffusion cell apparatus for patches remains ...

By hqt

2026-04-24

What Is A Pharmaceutical Dissolution Apparatus

What Is A Pharmaceutical Dissolution Apparatus? A Complete Guide To USP Apparatus Types 1–7

What Is A Pharmaceutical Dissolution Apparatus? This device of precision engineering assesses the rate of dissolution of active pharmaceutical ingredients in a tablet or capsule form. This dissolution method is ...

By hqt

2026-04-22

Pharmaceutical Dissolution Equipment Supplier

No Cross-Contamination: A Pharmaceutical Dissolution Equipment Supplier's 2026 Answer

As a responsible Pharmaceutical Dissolution Equipment Supplier, Raytor knows that even trace carryover invalidates results, triggers costly OOS investigations, and harms regulatory credibility. By 2026, highly potent APIs and low-dose ...

By hqt

2026-04-21

Dissolution Testing For Enteric Coated Tablets

Automated Dissolution Testing For Enteric Coated Tablets: No More Manual Errors

Dissolution Testing for Enteric Coated Tablets remains a major bottleneck for QC laboratories because manual media changes and sampling create variability that masks true release profiles. As we look to ...

By hqt

2026-04-20